From the Archives: Do No Harm

This case study was published in the summer 1996 edition of Bioethics Forum. For a full archive of this publication click here.

To the medical director as physician, the accomplishment represents the true greatness of modern medicine, but to the physician as a medical director, the advancement poses an increasingly frequent conundrum.

The medication costs $400,000 a year and treating this one patient will severely compromise the bottom-line of this small and growing for-profit managed care company.
Money that had originally been budgeted for implementation of a high risk pregnancy outreach program will no longer be available.

Click here for the full case study and let us know what you think by clicking on "Comments."